ReviewBMC medicine2025
Early life adversity and risk for non-communicable health outcomes: challenges and opportunities for a maturing field.
Review in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From Molecules to Meaning: Integrating Neuropeptides, Sociostasis, and Hormesis in the Brain-Heart Axis.Current issues in molecular biology · 2026Review
- Association of cord blood betatrophin with birth weight and fetal insulin sensitivity in term newborns.Chinese medical journal · 2026Article
- Environmental determinants of neurotoxicity: role of heavy metals in neurological disorders.Frontiers in neurology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundThere is now a growing scientific consensus that the origins of many adult diseases may be attributed to exposure to adversity early in life. Research over the past several decades indicates that many of the most common forms of non-communicable conditions, including both physical and psychiatric disorders, share a common biological foundation involving disruptions to shared biological systems that are likely fundamentally shaped by exposure to early adversity. MAIN TEXT: Despite the enormous promise of existing work, opportunities for clinical translation remain limited. Thus, we argue that it is now crucial to pause and consider the directions in which the field needs to move to ensure continued progress with the aim of protecting at-risk youth against the development of life-long disease. We first review recent work that has meaningfully contributed to a developmental cascade model wherein early life adversity sets off a cascade of dysregulations in the neuroendocrine, immune, and metabolic systems, which bidirectionally influence and are influenced by neural and epigenetic factors. We then outline four key directions for future work that we contend must be emphasized to maximize the clinical impact of this maturing field, including cross-disciplinary collaborations, multi-biomarker approaches, modeling disease processes prior to illness onset, and nuanced characterization of the early environment.
conclusionsRecent work highlights nuanced pathways through which early life adversity contributes to the development of a biological foundation underlying risk for non-communicable conditions. We contend that it is crucial to reflect on future research directions to ensure continued progress and opportunities for clinical translation, as the development of an increasingly sophisticated understanding of the pathways linking adversity to illness holds enormous promise for our ability to promote health and prevent disease among at-risk youth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.